Yengo et al. (2025) “Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations” Frontiers in Immunology.
Read about Yengo et al. (2025) “Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations” Frontiers in Immunology.
Lawtrakulngam et al. (2025) “Enhancing osseointegration with LNP-delivered mRNA–encoded BMP-2: An experimental in vivo study” Clinical Oral Implants Research.
DOI: 10.1111/clr.70057
Read about Lawtrakulngam et al. (2025) “Enhancing osseointegration with LNP-delivered mRNA–encoded BMP-2: An experimental in vivo study” Clinical Oral Implants Research.
Janjuha et al. (2025) “Spatial profiling of gene editing by in situ sequencing in mice and macaques” Nature Biomedical Engineering.
DOI: 10.1038/s41551-025-01512-7
Read about Janjuha et al. (2025) “Spatial profiling of gene editing by in situ sequencing in mice and macaques” Nature Biomedical Engineering.
Shuvaev et al. (2025) “Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo” PNAS.
DOI: 10.1073/pnas.2409266122
Read about Shuvaev et al. (2025) “Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo” PNAS.
Surisaeng et al. (2025) “BMP-2 mRNA-transfected BMSCs promote superior calvarial bone regeneration” Scientific Reports.
DOI: 10.1038/s41598-025-99979-6
Read about Surisaeng et al. (2025) “BMP-2 mRNA-transfected BMSCs promote superior calvarial bone regeneration” Scientific Reports.
Acuitas Therapeutics named one of Canada’s Top Small & Medium Employers of 2025
Read about Acuitas Therapeutics named one of Canada’s Top Small & Medium Employers of 2025
Acuitas Therapeutics named one of BC’s Top Employers of 2025
Read about Acuitas Therapeutics named one of BC’s Top Employers of 2025
Tremblay et al. (2025) “A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels” Nature Medicine.
DOI: 10.1038/s41591-025-03508-x
Read about Tremblay et al. (2025) “A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels” Nature Medicine.
PUBLICATION ALERT: High-throughput quantification and characterization of dual payload mRNA/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays
Read about PUBLICATION ALERT: High-throughput quantification and characterization of dual payload mRNA/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays
Imiolek et al. (2025) “High-throughput quantification and characterization of dual payload mRNA/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays” Analytical Chemistry.
DOI: 10.1021/acs.analchem.4c06296
Read about Imiolek et al. (2025) “High-throughput quantification and characterization of dual payload mRNA/LNP cargo via deformulating size exclusion and ion pairing reversed phase assays” Analytical Chemistry.
PUBLICATION ALERT: Restoring hematopoietic stem and progenitor cell function in Fancc−/− mice by in situ delivery of RNA lipid nanoparticles
Read about PUBLICATION ALERT: Restoring hematopoietic stem and progenitor cell function in Fancc−/− mice by in situ delivery of RNA lipid nanoparticles
Banda et al. (2025) “Restoring hematopoietic stem and progenitor cell function in Fancc−/− mice by in situ delivery of RNA lipid nanoparticles” Molecular Therapy.
DOI: 10.1016/j.omtn.2024.102423
Read about Banda et al. (2025) “Restoring hematopoietic stem and progenitor cell function in Fancc−/− mice by in situ delivery of RNA lipid nanoparticles” Molecular Therapy.